About BioStable
BioStable is a company based in Austin (United States) founded in 2008.. BioStable has raised $9.95 million across 3 funding rounds from investors including Orlando Health, Rex Health Ventures and Sante Ventures. BioStable offers products and services including HAART 300 and HAART 200. BioStable operates in a competitive market with competitors including Shockwave Medical, Cardiac Dimensions, Venus MedTech, Pi-Cardia and Symetis, among others.
- Headquarter Austin, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Corcym Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$9.95 M (USD)
in 3 rounds
-
Latest Funding Round
$4.2 M (USD), Series A
Feb 01, 2020
-
Investors
Orlando Health
& 2 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of BioStable
BioStable offers a comprehensive portfolio of products and services, including HAART 300 and HAART 200. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Device for repairing trileaflet aortic valves by resizing annulus.
Device for repairing bicuspid aortic valves to stabilize structure.
Unlock access to complete
Board Team
3 people
Leadership Team
3 people
Operations Team
1 people
Sales and Marketing
1 people
Unlock access to complete
Funding Insights of BioStable
BioStable has successfully raised a total of $9.95M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $4.2 million completed in February 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series A — $4.2M
-
First Round
First Round
(01 Aug 2008)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2020 | Amount | Series A - BioStable | Valuation | Orlando Health , Rex Health Ventures |
|
| Dec, 2008 | Amount | Series A - BioStable | Valuation |
investors |
|
| Aug, 2008 | Amount | Seed - BioStable | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in BioStable
BioStable has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include Orlando Health, Rex Health Ventures and Sante Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Chain of multispecialty hospital
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by BioStable
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - BioStable
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Biostable Comparisons
Competitors of BioStable
BioStable operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Shockwave Medical, Cardiac Dimensions, Venus MedTech, Pi-Cardia and Symetis, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Cardiovascular balloon dilation catheters with lithotripsy electrodes are developed.
|
|
| domain | founded_year | HQ Location |
Invasive cardiac implants for heart failure treatment are developed.
|
|
| domain | founded_year | HQ Location |
Transcatheter aortic and pulmonic valves are developed for cardiovascular procedures.
|
|
| domain | founded_year | HQ Location |
Non-implant devices for cardiac valve repair are developed and manufactured.
|
|
| domain | founded_year | HQ Location |
Minimally invasive heart valve replacement devices are developed and marketed.
|
|
| domain | founded_year | HQ Location |
Medical devices for cardiac and cerebrovascular treatments are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Biostable
Frequently Asked Questions about BioStable
When was BioStable founded?
BioStable was founded in 2008.
Where is BioStable located?
BioStable is headquartered in Austin, United States. It is registered at Austin, Texas, United States.
Is BioStable a funded company?
BioStable is a funded company, having raised a total of $9.95M across 3 funding rounds to date. The company's 1st funding round was a Seed of $250K, raised on Aug 01, 2008.
What does BioStable do?
The HAART device, intended for resizing, reshaping, and stabilizing the aortic valve, is being developed by BioStable, founded in 2008 in Austin, United States. Focus is placed on medical devices within the cardiac surgery sector. Collaboration occurs with J. Scott Rankin, MD, a Nashville-based cardiac surgeon. Investments have been secured from Sante Ventures and Tristar Technology Ventures. FDA approval for the device remains pending.
Who are the top competitors of BioStable?
BioStable's top competitors include Shockwave Medical, Cardiac Dimensions and JenaValve Technology.
What products or services does BioStable offer?
BioStable offers HAART 300 and HAART 200.
Who are BioStable's investors?
BioStable has 3 investors. Key investors include Orlando Health, Rex Health Ventures, and Sante Ventures.